Structures by: Lombard J.
Total: 16
Hexamethylenetetramine hydrogen succinate succinic acid
C6H13N4,C4H5O4,C4H6O4
CrystEngComm (2020) 22, 45 7826-7831
a=9.6037(4)Å b=9.8432(4)Å c=10.2613(4)Å
α=68.903(1)° β=83.980(1)° γ=68.045(1)°
4,4-bipyridinium bis(hydrogen oxalate)
C10H10N2,2(C2HO4)
CrystEngComm (2020) 22, 45 7826-7831
a=3.6795(7)Å b=9.855(2)Å c=10.425(2)Å
α=116.097(2)° β=97.436(2)° γ=97.188(2)°
4,4-bipyridinium bis(hydrogen oxalate)
C10H10N2,2(C2HO4)
CrystEngComm (2020) 22, 45 7826-7831
a=3.7614(3)Å b=9.8932(7)Å c=10.4498(7)Å
α=116.121(1)° β=96.721(1)° γ=98.409(1)°
Hexamethylenetetramine hydrogen succinate succinic acid
C6H13N4,C4H5O4,C4H6O4
CrystEngComm (2020) 22, 45 7826-7831
a=9.6812(2)Å b=9.8923(2)Å c=10.3777(3)Å
α=70.346(1)° β=83.328(1)° γ=67.442(1)°
Hexamethylenetetramine succinic acid
C4H6O4,C6H12N4
CrystEngComm (2020) 22, 45 7826-7831
a=6.017(1)Å b=18.340(3)Å c=11.778(2)Å
α=90° β=99.387(3)° γ=90°
4,4-bipyridine oxalic acid
2(C10H8N2),2(C2H2O4)
CrystEngComm (2020) 22, 45 7826-7831
a=8.740(1)Å b=9.849(1)Å c=13.663(2)Å
α=73.285(2)° β=72.292(2)° γ=72.343(2)°
4,4-bipyridine oxalic acid
2(C10H8N2),2(C2H2O4)
CrystEngComm (2020) 22, 45 7826-7831
a=8.7731(5)Å b=9.8652(5)Å c=13.9929(7)Å
α=73.741(2)° β=72.890(2)° γ=72.483(2)°
(Z)-3-carbamoyl-1-(3-carboxy-1,1-dihydroxyprop-2-en-1-ide-2-yl) pyridin-1-ium
C10H8N2O5
CrystEngComm (2018) 20, 1 25
a=8.8986(17)Å b=7.9933(15)Å c=14.175(3)Å
α=90° β=97.628(3)° γ=90°
C6H7N2O,0.5(C4O4)
C6H7N2O,0.5(C4O4)
CrystEngComm (2018) 20, 1 25
a=3.671(3)Å b=7.594(5)Å c=13.772(10)Å
α=95.723(8)° β=93.218(8)° γ=97.153(8)°
2,4,6-triamino-1,3,5-triazin-1-ium 2-(4-cyanopyridin-1-ium-1-yl)fumarate hydrate
C10H5N2O4,C3H7N6,H2O
CrystEngComm (2018) 20, 1 25
a=17.184(15)Å b=7.328(5)Å c=13.045(9)Å
α=90° β=111.257(10)° γ=90°
(Z)-4-carbamoyl-1-(3-carboxy-1,1-dihydroxyprop-2-en-1-ide-2-yl) pyridin-1-ium
C10H8N2O5,H2O
CrystEngComm (2018) 20, 1 25
a=7.2047(11)Å b=7.5455(11)Å c=10.8058(16)Å
α=91.800(2)° β=100.509(2)° γ=115.757(2)°
1,3,5-triazine-2,4,6-triamine (Z)-2-(3-carbamoylpyridin-1-ium-1-yl) -1,1-dihydroxybut-2-en-1-ideoate dihydrate
C10H7N2O5,C3H7N6,2(H2O)
CrystEngComm (2018) 20, 1 25
a=5.7312(5)Å b=12.3326(10)Å c=12.8974(11)Å
α=71.530(2)° β=86.574(3)° γ=89.673(3)°
1,3,5-triazine-2,4,6-triamine (Z)-2-(4-carbamoylpyridin-1-ium-1-yl) -1,1-dihydroxybut-2-en-1-ideoate dihydrate
C10H7N2O5,C3H7N6,H2O
CrystEngComm (2018) 20, 1 25
a=8.6886(3)Å b=8.9638(3)Å c=11.2137(4)Å
α=94.473(2)° β=103.931(2)° γ=106.6570(10)°
Bis-hexamethylenetetramine succinic acid
C4H6O4,2(C6H12N4)
CrystEngComm (2020) 22, 45 7826-7831
a=21.847(1)Å b=6.9981(4)Å c=26.359(2)Å
α=90° β=102.170(1)° γ=90°
Hexamethylenetetramine succinic acid
C4H6O4,C6H12N4
CrystEngComm (2020) 22, 45 7826-7831
a=5.8215(8)Å b=18.363(2)Å c=11.592(2)Å
α=90° β=100.266(2)° γ=90°
Bis-hexamethylenetetramine succinic acid
C4H6O4,2(C6H12N4)
CrystEngComm (2020) 22, 45 7826-7831
a=21.654(3)Å b=6.948(1)Å c=25.748(4)Å
α=90° β=101.148(2)° γ=90°